Medico Remedies Limited

Medico Remedies Limited (MEDICO) is a micro-cap Healthcare company valued at ₹182 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Medico Remedies Limited last traded at ₹22.09, modestly up 0.82% on the day.

Recent developments

On 2026-06-30, the company reported its latest quarter results, showing strong revenue and profit growth compared to the same period last year. The promoter holding remained at 61.38%, with foreign institutional holdings increasing by 0.05 percentage points.

Financial performance

The company's business is improving, with annual revenue rising 36.7% and annual net profit growing 31.2%. The latest quarter saw revenue surge 81.4% and net profit jump 38.5% compared to the same quarter a year earlier, though the net profit margin narrowed slightly to 6.4% from 6.6%.

Valuation multiples

The stock trades at 14.0 times earnings, a discount to the Healthcare median of 32.0, 3.96 times book value.

Things to watch

The stock is 61.6% below its 52-week high, and the company has not paid any dividends despite reporting profits. The net profit margin declined by 0.3 percentage points, which may indicate rising costs or lower pricing power.

Where it stands

Medico Remedies Limited has shown strong revenue and profit growth in the latest quarter, with both metrics rising significantly year-over-year. The company's promoter holding remains dominant, but its stock is far below its recent peak. The narrowing net profit margin is the most notable factor in its current performance.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.